See what is changing in cancer research

Signal Engine searches cancer-research sources, connects related findings, weighs their importance, and shows what each answer rests on. Conversation is with a language model.

Research orientation. The answer is built from Signal Engine indexed sources, not from the model’s general knowledge.

Domains

• Cancer research — Publications, biological targets, drugs, evidence levels, and clinical trials.

Signals

• Combinations Targeting EGFR and KRAS G12C May Advance NSCLC Treatment — NSCLC
• Diffuse Large B-Cell Lymphoma - PMC — Diffuse large B-cell lymphoma
• The Revolution of Targeted Therapies in Thyroid Cancer Treatment: Present and Future Promising Anti-Cancer Drugs — Thyroid cancer
• Clinical Impact of EGFR Mutation Subtypes on Treatment Outcomes in Advanced Non-Small Cell Lung Cancer: An Austrian Real-World Study — NSCLC
• A spatial immune scoring system based on the tumor microenvironment features improves prognostic stratification in lung adenocarcinoma — NSCLC
• ADC – ANTIBODY-DRUG CONJUGATES IN ONCOLOGY — Breast cancer
• Dr. Joseph Mikhael — Multiple myeloma
• A phase II study assessing the feasibility and clinical efficacy of adaptive immunotherapy combination with VEGFR-TKI in patients with advanced renal cell carcinoma. — Renal cell carcinoma
• MSK Research Highlights, September 14, 2026 — Colorectal cancer
• A Diagnostic Challenge: Retroperitoneal Extraskeletal Ewing Sarcoma with Subaortic Growth and Partial Aortic Encasement Presenting with Nephrolithiasis-Like Symptoms in a Middle-Aged South Asian Male — Ewing sarcoma
• Anal cancer: research and therapeutic landscape — Anal squamous cell carcinoma
• Ropeginterferon alfa‑2b‑njft treatment in essential thrombocythemia across different driver mutations: results from a North American, single‑arm, multicentre study (EXCEED‑ET) — Acute myeloid leukemia